// Pages are code-split (React.lazy) so visitors only download the page they open.
Only pay if approved·Free shipping·Cancel anytime·Provider supervised·HIPAA secure

Provider-prescribed treatments. Subject to medical evaluation. Medications are dispensed by licensed U.S. pharmacies.

Back to Blog
Comparisons
🔗 Linkable Asset 5/17/2026 7 min readBy EdenRx Medical Team

Tirzepatide vs Semaglutide Results: What the Research Suggests

Tirzepatide vs Semaglutide Results: What the Research Suggests

Ready to find out if you may qualify?

No payment required to start · Takes less than 60 seconds · Only pay if approved

Check Your Eligibility Free
No Payment Required Response Within 24h Built from Eden Med Spa

Key Takeaways

  • 1Clinical trials suggest tirzepatide may produce greater average weight loss (~20-22%) compared to semaglutide (~14.9%), though individual results vary and no outcomes are guaranteed.
  • 2Both medications are once-weekly injectables with similar side effect profiles; tirzepatide's dual GIP + GLP-1 mechanism may contribute to its potentially stronger appetite suppression.
  • 3A licensed provider review is essential for determining which medication, if any, is appropriate — EdenRx offers free assessments for eligible patients in Florida and New York.

Both tirzepatide and semaglutide have shown meaningful weight loss potential in large-scale clinical trials, with tirzepatide potentially producing greater average reductions in body weight based on head-to-head and comparative data — though individual results vary and a qualified provider must determine which medication, if any, is appropriate for you.

Ready to find out if you qualify? Start Free Assessment — No payment required


How Each Medication Works

Semaglutide is a GLP-1 receptor agonist, meaning it mimics the glucagon-like peptide-1 hormone to help regulate blood sugar, slow gastric emptying, and reduce appetite. It has been studied extensively under brand names used for both diabetes management and chronic weight management. Patients who may be eligible for semaglutide through a program like EdenRx's GLP-1 weight loss program typically receive a weekly injectable dose that escalates over time to improve tolerability.

Tirzepatide, on the other hand, is a dual GIP and GLP-1 receptor agonist — it targets two incretin hormone pathways rather than one. This dual-action mechanism is believed to contribute to its potentially stronger appetite suppression and metabolic effects. Because it works on an additional receptor, tirzepatide may influence energy intake and fat storage in ways that differ meaningfully from semaglutide alone, though research continues to evolve.


What the Clinical Research Suggests About Results

In the SURMOUNT-1 trial, adults taking tirzepatide at the highest studied dose experienced an average body weight reduction of approximately 20–22% over 72 weeks, depending on the dose studied. In the STEP-1 trial for semaglutide, participants experienced an average reduction of approximately 14.9% of body weight over 68 weeks. These are averages from controlled settings — real-world results vary based on adherence, lifestyle, and individual physiology.

A 2023 retrospective analysis and several indirect comparisons have suggested that tirzepatide may lead to greater average weight loss than semaglutide, but these are not perfect apples-to-apples comparisons since the trials used different populations and protocols. Direct head-to-head trials are ongoing. What both medications share is a clinically meaningful potential to support weight reduction when combined with behavioral changes — something EdenRx emphasizes across all of its weight loss programs.


Tirzepatide vs Semaglutide: Side-by-Side Comparison

The table below summarizes key differences based on current research. This is for informational purposes only and does not constitute medical advice.

| Feature | Semaglutide | Tirzepatide | |---|---|---| | Mechanism | GLP-1 receptor agonist | Dual GIP + GLP-1 receptor agonist | | Avg. Weight Loss (trials) | ~14.9% body weight | ~20–22% body weight | | Dosing | Once weekly injection | Once weekly injection | | FDA Approval (obesity) | Yes (Wegovy) | Yes (Zepbound) | | Common Side Effects | Nausea, vomiting, diarrhea | Nausea, vomiting, diarrhea | | Availability via EdenRx | If eligible (FL & NY) | If eligible (FL & NY) | | Provider Required | Yes | Yes |

As you can see, both medications share a similar administration schedule and side effect profile. The most notable potential difference is in the magnitude of average weight loss. However, eligibility, cost, tolerability, and your personal health history all factor into which option may be best suited for you. Explore EdenRx pricing to understand cost considerations before your consultation.


Side Effects and Tolerability

Both medications share a similar tolerability profile, with gastrointestinal side effects being the most commonly reported. Nausea, vomiting, constipation, and diarrhea are frequently noted during the dose escalation phase, though many patients find these effects subside over time. Neither medication is appropriate for individuals with a personal or family history of certain thyroid conditions or pancreatitis, among other contraindications.

Some patients may find one medication easier to tolerate than the other — and this is yet another reason why individual provider review is so important. If you have tried one GLP-1 medication with limited success or significant side effects, switching to the other may potentially be an option, but only under the supervision of a licensed provider. EdenRx's online weight loss program is designed with ongoing provider review built into every step.


How GLP-1 Medications Compare to Diet Alone

One of the most common questions patients ask is whether medication is truly necessary — couldn't diet and exercise achieve similar results? While lifestyle changes remain foundational to any weight loss approach, research consistently suggests that GLP-1 medications may offer substantially greater average outcomes than diet modification alone for individuals with obesity or overweight with related health conditions. Our dedicated resource on GLP-1 vs diet alone explores this topic in depth.

It is important to note that GLP-1 medications are not a replacement for healthy behaviors — they are a potential tool to help make those behaviors more sustainable by reducing hunger signals and improving metabolic function. Most clinical trials for both tirzepatide and semaglutide were conducted alongside lifestyle intervention components, meaning the best results are potentially achieved when medication is paired with dietary and activity changes that your care team can help you develop.


Why Provider Review Matters

Choosing between tirzepatide and semaglutide is not a decision that should be made based on a blog post, a social media trend, or a friend's experience — and EdenRx is built around that principle. Every patient who goes through the free assessment is reviewed by a licensed provider who evaluates medical history, current medications, weight loss goals, and other individual factors before any recommendation is made. This is what separates a responsible telehealth platform from a one-size-fits-all supplement shop.

Provider review also matters because both tirzepatide and semaglutide are prescription medications that carry real risks if used without appropriate oversight. Contraindications exist, drug interactions are possible, and ongoing monitoring is important to ensure safety and effectiveness. At EdenRx, our team does not simply issue a prescription and disappear — we are a partner in your weight loss journey, with structured check-ins and care support for patients in Florida and New York who may be eligible. Results vary, and no outcomes are guaranteed.

Ready to take the next step? See if you qualify today — Provider-reviewed, no upfront payment required. Available to eligible patients in FL and NY.


Built from Eden Med Spa — real patients, real treatments.


Conclusion

When comparing tirzepatide vs semaglutide results, the research suggests tirzepatide may potentially offer greater average weight loss based on available clinical data — but "greater on average" does not mean "better for you specifically." Your health history, insurance considerations, medication tolerance, and provider's clinical judgment all play a role in determining which path may be most appropriate. Both medications have demonstrated meaningful potential in peer-reviewed trials, and both are available through EdenRx's GLP-1 weight loss program for eligible patients.

If you are in Florida or New York and are curious about whether either of these medications may be right for you, the best first step is a provider-reviewed assessment. There is no payment required to get started, and our team is here to give you honest, evidence-informed guidance — not a sales pitch. Start your free assessment today and let a licensed provider help you find the option that fits your life.


Frequently Asked Questions

See if you qualify in 60 seconds

Provider-reviewed · Only pay if approved · Cancel anytime

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
tirzepatide semaglutide GLP-1 weight loss medication telehealth tirzepatide vs semaglutide results EdenRx Florida New York obesity treatment comparisons

Share This Article

Share Text

Tirzepatide vs semaglutide — what does the research actually say? We compare both GLP-1 medications side by side. Results vary; a provider review matters. 👉 tryedenrx.org/tirzepatide-vs-semaglutide-results

No payment required to start — get up to $50 off your first month.

A licensed provider reviews every case. Only pay if approved. Cancel anytime.

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
Live Activity
141 people online now
1,054 visits today
9 orders shipped today
HIPAA Secure